ALLR
USDAllarity Therapeutics Inc. Common Stock
$1.295-0.035 (-2.632%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$1.330
High
$1.340
Low
$1.280
Volume
0.38M
Company Fundamentals
Market Cap
18.8M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
7.00M
Exchange
NCM
Currency
USD
52-Week Range
Low $0.614Current $1.295High $2.35
Related News
Analyst Upgrades
Ascendiant Capital Maintains Buy on Allarity Therapeutics, Raises Price Target to $9.25
Ascendiant Capital analyst Edward Woo maintains Allarity Therapeutics with a Buy and raises the price target from $9 to $9.25.
View more
GlobeNewswire
Allarity Therapeutics Presents New Phase 2 Clinical Data for Stenoparib/2X-121 Showing Landmark Median Overall Survival Has Now Surpassed 25 Months
- Kaplan-Meier analyses show for the first time that median Overall Survival exceeds 25 months for Platinum Resistant and Refractory Ovarian Cancer Patients receiving stenoparib/2X-121 twice daily - Two patients
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.